Low-Risk Cannabis Users After Canadian Legalization: Who Are They and What Distinguishes Them?
Most public health research on cannabis focuses on what goes wrong - who develops dependence, who experiences psychosis, whose cognitive function declines. A study led by the Universite de Montreal's School of Public Health takes the opposite approach, asking who uses cannabis without apparent harm and what distinguishes them. Four to five years after Canada legalized recreational cannabis, the answer involves frequency, mental health, and social context more than demographics.
The research, led by Professor Marie-Pierre Sylvestre, analyzed data from a longitudinal cohort of Canadian adults tracked through and after legalization. Rather than categorizing participants by whether they used cannabis or not, it examined the profiles of users who showed no indicators of problematic use or dependence after several years of legal access to the drug.
What "Low Risk" Means in This Context
The study operationalized low-risk cannabis use against validated clinical screening instruments for cannabis use disorder and abuse, alongside self-reported measures of interference with daily functioning. Adults classified as low-risk reported using cannabis without meeting diagnostic criteria for dependence, without describing interference with work, relationships, or health, and without escalating their use over the follow-up period.
This definition is deliberately functional rather than based on frequency thresholds alone. A person who uses cannabis weekly and reports no functional impairment would qualify; a person who uses it rarely but experiences craving and loss of control would not. This approach aligns with public health frameworks that have moved away from treating any cannabis use as inherently problematic toward assessing use in terms of actual outcomes.
Who Shows Up in the Low-Risk Profile
The analysis identified several factors consistently associated with remaining in the low-risk category across the follow-up period. Infrequent use - monthly or less - was the strongest predictor. Adults who used cannabis no more than once or twice per month were substantially less likely to develop patterns associated with dependence than those who used weekly or more.
Mental health status played a significant role. Adults with anxiety or depression at baseline were more likely to transition out of the low-risk category over time, consistent with a body of evidence showing that these conditions both elevate risk of cannabis use disorder and are often implicated in self-medication patterns that can escalate use. Adults with stable mental health and no prior history of substance use problems were disproportionately represented in the persistent low-risk group.
Social and economic stability - measured through employment status, relationship quality, and housing security - also differentiated low-risk from higher-risk users. This mirrors findings from other substance use research suggesting that social stability buffers against problematic patterns across multiple substances.
What Legalization Did and Did Not Change
The Canadian legalization context is important for interpreting these findings. Legalization dramatically expanded the range of products available, reduced the legal risk of use, and to some extent normalized cannabis consumption. Whether legalization itself increased rates of problematic use in the broader population is a separate question that this study was not designed to answer.
What the data show is that a substantial portion of adult cannabis users in the post-legalization period use it without developing the markers of problematic use that clinicians and public health researchers monitor. This finding has implications for how harm reduction messages are targeted: resources and interventions may be most efficiently directed toward the subgroups identified as higher risk - those with pre-existing mental health vulnerabilities, those using frequently, and those in less stable social circumstances.
Limitations of the Approach
Self-reported measures of cannabis use and functional impact carry well-documented reliability problems. People may underreport use, underestimate interference with functioning, or have different thresholds for what constitutes a problem with their use. The longitudinal cohort, while valuable for tracking change over time, may have experienced differential dropout: people who developed more severe cannabis problems might have been less likely to remain in the study, potentially inflating the proportion of low-risk users in later waves.
The four-to-five year follow-up period captures a specific phase of post-legalization Canada and may not reflect patterns that would emerge over longer time horizons. Cannabis use disorder can develop gradually over many years of use, and a study covering less than a decade may miss transitions from low-risk to problematic use that take longer to manifest.
Public Health Framing of Legal Substance Use
The study's framing reflects a broader shift in public health research toward cannabis, which parallels approaches long used for alcohol: accepting that many people will use the substance legally, and focusing research effort on who is at risk of harm and why, rather than treating all use as inherently problematic. This orientation supports more targeted prevention and harm reduction rather than blanket abstinence messaging that has proven ineffective in general populations.